Placentrex

Placentrex Gel is a topical medication used to treat wounds that are not healing or healing very slowly. It promotes wound healing with minimal scars

Product dosage: 20g
Package (num)	Per tube	Price	Buy
3	$18.00	$54.00 (0%)	🛒 Add to cart
4	$17.50	$72.00 $70.00 (3%)	🛒 Add to cart
5	$17.00	$90.00 $85.00 (6%)	🛒 Add to cart
6	$16.50	$108.00 $99.00 (8%)	🛒 Add to cart
7	$16.14	$126.00 $113.00 (10%)	🛒 Add to cart
8	$15.75	$144.00 $126.00 (12%)	🛒 Add to cart
9	$15.33	$162.00 $138.00 (15%)	🛒 Add to cart
10	$14.90 Best per tube	$180.00 $149.00 (17%)	🛒 Add to cart

Placentrex is a biologically derived therapeutic agent, formulated from human placental extract, designed to support and accelerate tissue regeneration and wound healing processes. As a prescription medication, it is indicated for a range of conditions where cellular repair, anti-inflammatory action, and angiogenesis are clinically desired. Its mechanism is rooted in modulating the body’s innate healing pathways, offering a targeted approach to managing chronic ulcers, non-healing wounds, and certain inflammatory disorders. This expert-oriented guide provides a comprehensive overview of Placentrex, detailing its pharmacological profile, clinical applications, administration protocols, and essential safety information for healthcare professionals and informed patients.

Features

• Active Ingredient: Human placental extract (biological origin)
• Presentation: Available in injectable (gel and solution) and topical ointment formulations
• Pharmacological Class: Tissue regenerative and reparative agent
• Primary Actions: Promotes granulation tissue formation, stimulates angiogenesis, exhibits anti-inflammatory and analgesic properties
• Sterility: Manufactured under strict aseptic conditions; meets pharmacopoeial standards for biological products

Benefits

• Accelerates Wound Epithelialization: Significantly reduces healing time for chronic wounds and ulcers by promoting rapid cell proliferation and tissue formation.
• Modulates Inflammation: Exerts a potent anti-inflammatory effect, reducing swelling, pain, and exudate in affected tissues, thereby improving patient comfort.
• Enhances Local Microcirculation: Stimulates the development of new blood vessels (angiogenesis), improving oxygen and nutrient supply to damaged areas.
• Supports Scar Modulation: Aids in organized collagen deposition, potentially reducing hypertrophic or keloid scar formation post-healing.
• Provides Analgesic Relief: Helps alleviate localized pain associated with inflammatory conditions and non-healing wounds.

Common use

Placentrex is commonly used in clinical practice for the management of conditions characterized by impaired healing and chronic inflammation. Its primary indications include the treatment of non-healing wounds such as diabetic foot ulcers, venous stasis ulcers, and pressure sores. It is also employed in postoperative wound care to enhance recovery and minimize complications. Additionally, it finds application in managing certain inflammatory disorders like osteoarthritis (as intra-articular injections), pelvic inflammatory disease, and radiation-induced tissue damage. Dermatological uses include the management of burns, non-specific ulcers, and certain scar tissues. Usage should always be under medical supervision with a clear diagnostic rationale.

Dosage and direction

Administration must be performed by a qualified healthcare professional. Dosage is individualized based on condition severity, patient response, and formulation.

• Injectable Form (Gel/Solution): Typically administered via local infiltration, intramuscular injection, or intra-articular injection. A common regimen is 2 mL administered 2-3 times per week, though frequency and duration are determined by the treating physician. The course may extend from several weeks to months based on therapeutic response.
• Topical Ointment: Apply a thin layer to the affected area 2-3 times daily after cleansing the wound. Cover with a sterile dressing if indicated.
• Always use aseptic technique. Do not self-administer injectable forms.

Precautions

• Use with caution in patients with a history of hypersensitivity to biological products.
• Avoid administration into infected tissues; treat active infection first.
• Pregnancy and lactation: Use only if clearly needed and under strict medical supervision, as safety data is limited.
• Not recommended for intravenous administration.
• Monitor for local reactions at the injection site.
• Store as directed; do not use if packaging is compromised or product appears altered.

Contraindications

• Known hypersensitivity to any component of Placentrex or human placental extracts.
• Active systemic infections or untreated localized infections at the proposed site of administration.
• History of severe allergic or anaphylactic reactions to biological therapies.
• Not intended for use in malignancies or suspected malignant tissues.

Possible side effect

Placentrex is generally well-tolerated when administered correctly. Possible side effects are usually mild and localized.

• Injection site reactions: Pain, redness, swelling, or induration.
• Mild fever or transient discomfort.
• Allergic reactions: Rash, itching, or urticaria; in rare cases, anaphylaxis.
• Systemic effects are uncommon but may include malaise or headache. Discontinue use and seek medical attention if severe reactions occur.

Drug interaction

Formal drug interaction studies are limited. However:

• Theoretical potential for interactions with other immunomodulatory or biological agents.
• No known interactions with systemic analgesics or anti-inflammatory drugs, but concomitant use should be monitored.
• Always inform your physician of all medications, supplements, and therapies you are using.

Missed dose

If a scheduled dose is missed, administer it as soon as possible. If it is almost time for the next dose, skip the missed dose and resume the regular schedule. Do not double the dose to catch up. Consult the prescribing physician for guidance specific to your treatment plan.

Overdose

There are no well-documented cases of overdose. Given its localized use and biological nature, systemic overdose is unlikely. Excessive dose or frequency may increase the risk of local reactions or hypersensitivity. In case of suspected overdose, discontinue use and seek medical attention. Supportive and symptomatic treatment is recommended.

Storage

• Store in a refrigerator (2°C to 8°C). Do not freeze.
• Protect from light.
• Keep in original packaging until use.
• Do not use beyond the expiration date.
• For injectable forms: once opened or reconstituted, use immediately or as per manufacturer’s in-use stability recommendations.

Disclaimer

This information is for educational purposes and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for any health-related decisions. Do not initiate, alter, or discontinue therapy based solely on this content. The manufacturer and publisher are not liable for any outcomes resulting from the use or misuse of this information.

Reviews

Clinical and patient-reported outcomes generally reflect positive experiences with Placentrex, particularly in difficult-to-heal wounds and chronic inflammatory conditions. Many healthcare providers report observable improvements in granulation tissue formation and reduced healing time. Patients often note decreased pain and enhanced quality of life. However, individual responses can vary, and robust, large-scale clinical trial data is still evolving. Always rely on evidence-based practice and physician guidance.